(RTTNews) - Revvity, Inc. (RVTY), a diagnostic and health sciences company, Monday announced that it has entered into a definitive agreement to acquire ACD/Labs, a provider of scientific software ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

TORONTO--(BUSINESS WIRE)--ACD/Labs, an informatics company that develops and commercializes solutions in support of chemical and pharmaceutical R&D, today announced that Boehringer Ingelheim, a ...

ACD/Labs is seeing early stages of adoption of its software by the food and beverage industry as the sector looks for ways to boost data integrity. Graham McGibbon, director of strategic partnerships, ...

The informatics company that supports chemical and pharmaceutical R&D sectors said it enhances collaboration between process chemistry, analytical, regulatory and quality departments. Luminata offers ...

Open enterprise R&D platform speeds deployment of cutting-edge technology and science SAN DIEGO, Jul 27, 2011 (BUSINESS WIRE) -- Accelrys, Inc. /quotes/zigman/93157 ACCL +5.67% , a leading scientific ...

ACD/Labs, announced a new release of Katalyst D2D®, the industry-leading software for workflow digitalization and data management in chemical and process development. “This release of Katalyst D2D is ...

ACD/Labs, an informatics company that develops and commercializes software in support of R&D, today announced the much-anticipated release of the first commercial browser-based NMR processing software ...

Revvity, Inc. (NYSE: RVTY), today announced it has entered into a definitive agreement to acquire ACD/Labs, a global provider of scientific software solutions that support analytical characterization ...